⚖ Compare news

Put up to three stories side by side. Pick IDs from any article URL: /compare?id=123&id=456

India orders top drugmaker to halt eye medicine production at plant over quality lapses

channelnewsasia.com ·Singapore · health
Words
26
Chars
193
AI summary
Yes
Full story

Indian regulators have taken action against Sun Pharma, the largest drugmaker in the country. The company is now barred from producing ophthalmic drugs at its factory located in Assam. This restriction will remain in place until the company provides a compliance report that regulators find satisfactory. The decision follows reports of quality lapses at the plant.

Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.

Open article